News and Announcements
Prescient Therapeutics Investor Presentation April 2016
- Published April 13, 2016 11:52AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
13th April 2016, ASX Announcement
Investment Summary: Why all the excitement about AML?
- Acute Myeloid Leukemia (AML) is an area of substantial unmet medical need.
– One of the worst survival rates of all cancers
– Standard of care unchanged for 40 years - A disease of intense interest for clinicans, pharma companies and investors
- Celator Pharmaceuticals (NASDAQ: CPXX) showed what can happen when enhancing the standard of care in AML
– Market cap recently surged from small cap to $780M
-Dr Jeff Lancet was the Principal Investigator on CPXX’s ground-breaking trial - PTX has successful Phase 1 trial in AML (conducted at Moffitt and MD Anderson)
To view the full article please click on the button below.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
